251 related articles for article (PubMed ID: 30718416)
61. Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3.
Böcker S; Laaf D; Elling L
Biomolecules; 2015 Jul; 5(3):1671-96. PubMed ID: 26213980
[TBL] [Abstract][Full Text] [Related]
62. Lectinology 4.0: Altering modular (ga)lectin display for functional analysis and biomedical applications.
Ludwig AK; Kaltner H; Kopitz J; Gabius HJ
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):935-940. PubMed ID: 30851406
[TBL] [Abstract][Full Text] [Related]
63. Fine-tuning of prototype chicken galectins: structure of CG-2 and structure-activity correlations.
Ruiz FM; Fernández IS; López-Merino L; Lagartera L; Kaltner H; Menéndez M; André S; Solís D; Gabius HJ; Romero A
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1665-76. PubMed ID: 23999290
[TBL] [Abstract][Full Text] [Related]
64. Exploring the Structural Space of the Galectin-1-Ligand Interaction.
Bertleff-Zieschang N; Bechold J; Grimm C; Reutlinger M; Schneider P; Schneider G; Seibel J
Chembiochem; 2017 Aug; 18(15):1477-1481. PubMed ID: 28503789
[TBL] [Abstract][Full Text] [Related]
65. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH
Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897
[TBL] [Abstract][Full Text] [Related]
66. Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.
Roy R; Cao Y; Kaltner H; Kottari N; Shiao TC; Belkhadem K; André S; Manning JC; Murphy PV; Gabius HJ
Histochem Cell Biol; 2017 Feb; 147(2):285-301. PubMed ID: 28013366
[TBL] [Abstract][Full Text] [Related]
67. Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric Recognition.
Roy R; Murphy PV; Gabius HJ
Molecules; 2016 May; 21(5):. PubMed ID: 27187342
[TBL] [Abstract][Full Text] [Related]
68. Role of Galectins in Multiple Myeloma.
Storti P; Marchica V; Giuliani N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
[TBL] [Abstract][Full Text] [Related]
69. Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma.
Wollina U; Graefe T; Feldrappe S; André S; Wasano K; Kaltner H; Zick Y; Gabius HJ
J Cancer Res Clin Oncol; 2002 Feb; 128(2):103-10. PubMed ID: 11862481
[TBL] [Abstract][Full Text] [Related]
70. Binding studies of adhesion/growth-regulatory galectins with glycoconjugates monitored by surface plasmon resonance and NMR spectroscopy.
Muñoz FJ; Santos JI; Ardá A; André S; Gabius HJ; Sinisterra JV; Jiménez-Barbero J; Hernáiz MJ
Org Biomol Chem; 2010 Jun; 8(13):2986-92. PubMed ID: 20461267
[TBL] [Abstract][Full Text] [Related]
71. Galectin-9 binds to O-glycans on protein disulfide isomerase.
Schaefer K; Webb NE; Pang M; Hernandez-Davies JE; Lee KP; Gonzalez P; Douglass MV; Lee B; Baum LG
Glycobiology; 2017 Sep; 27(9):878-887. PubMed ID: 28810662
[TBL] [Abstract][Full Text] [Related]
72. Galectins and other endogenous carbohydrate-binding proteins of animal bladder.
Bhavanandan VP; Puch S; Guo X; Jiang W
Adv Exp Med Biol; 2001; 491():95-108. PubMed ID: 14533792
[TBL] [Abstract][Full Text] [Related]
73. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
Bartolazzi A; Sciacchitano S; D'Alessandria C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
[TBL] [Abstract][Full Text] [Related]
74. Crosslinking of N-acetyllactosamine-containing glycoproteins to galectin-1 with an introduced cysteine using a photoactivatable sulfhydryl reagent.
Tamura M; Igarashi T; Kasai K; Arata Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):581-4. PubMed ID: 19819223
[TBL] [Abstract][Full Text] [Related]
75. Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair.
Dvořánková B; Szabo P; Lacina L; Gal P; Uhrova J; Zima T; Kaltner H; André S; Gabius HJ; Sykova E; Smetana K
Cells Tissues Organs; 2011; 194(6):469-80. PubMed ID: 21494018
[TBL] [Abstract][Full Text] [Related]
76. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
Sioud M; Mobergslien A; Boudabous A; Fløisand Y
Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
[TBL] [Abstract][Full Text] [Related]
77. Galectins-1 and -3 in Human Intervertebral Disc Degeneration: Non-Uniform Distribution Profiles and Activation of Disease Markers Involving NF-κB by Galectin-1.
Elshamly M; Kinslechner K; Grohs JG; Weinmann D; Walzer SM; Windhager R; Gabius HJ; Toegel S
J Orthop Res; 2019 Oct; 37(10):2204-2216. PubMed ID: 31115931
[TBL] [Abstract][Full Text] [Related]
78. Lactulose as a novel template for anticancer drug development targeting galectins.
Kishor C; Ross RL; Blanchard H
Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
[TBL] [Abstract][Full Text] [Related]
79. Human galectin-3 (Mac-2 antigen): defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region.
Krzeminski M; Singh T; André S; Lensch M; Wu AM; Bonvin AM; Gabius HJ
Biochim Biophys Acta; 2011 Feb; 1810(2):150-61. PubMed ID: 21070836
[TBL] [Abstract][Full Text] [Related]
80. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
